Multisensory and Cognitive Interventions in the ICU: Effects on Health and Recovery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAbant Izzet Baysal University

About this trial

The goal of this clinical trial is to examine the effects of sensory and cognitive stimulation on physiological, psychological, and functional recovery in adult patients after cardiac surgery who are treated in the intensive care unit (ICU). The main questions it aims to answer are:

* Does sensory and/or cognitive stimulation reduce anxiety and improve hemodynamic stability in ICU patients? * Does it enhance physical function and independence during early rehabilitation in the ICU?

Researchers will compare four groups:

1. Standard care (control), 2. Cognitive stimulation, 3. Auditory stimulation (music), 4. Multisensory stimulation (touch + smell)

to assess which intervention is most effective in improving recovery parameters.

Participants will:

* Be randomly assigned to one of four groups during early mobilization in the ICU * Receive a 30-minute intervention session depending on group assignment * Be evaluated for heart rate, blood pressure, oxygen saturation, anxiety (VAS), physical function (PFIT, FIM), and satisfaction before and after the session

Eligibility criteria

Qualifiers

Age between 18 and 80 years

Underwent coronary artery bypass grafting (CABG) or other open-heart surgery

Admitted to the ICU postoperatively and eligible for early mobilization

Hemodynamically stable (within normal blood pressure and heart rate ranges, without inotropic support)

Disqualifiers

Diagnosis of ICU delirium or altered mental status

Severe hemodynamic instability

Presence of neurological disease or significant cognitive impairment

Significant sensory deficits (e.g., severe hearing or vision loss)

Trial design

Treatments tested in this trial

  • Cognitive Exercises
  • Auditory Stimulation
  • Multisensory Stimulation

Treatment groups

125 Participants
are divided into 4 treatment groups

Sponsors and collaborators